Warning letter
Furst-McNess Company: warning letter of Mar 12, 2024
FDA warning letter 668925 · Division of Human and Animal Food Operations West I
Key facts
| Reference number | 668925 |
|---|---|
| Company | Furst-McNess Company |
| Subject | CGMP/Medicated Feeds/Adulterated |
| Issue date | Mar 12, 2024 |
| Posted date | Mar 19, 2024 |
| Issuing office | Division of Human and Animal Food Operations West I |
| Product type | Veterinary |
| CFR sections cited | 225, 225.142, 507, 507.39, 507.40, 507.42, 507.45, 225.1(b)(1), 507.1(a)(1)(ii), 507.34(a)(1), 507.49(a), 507.45(a)(2) |
| Inspection city | Lodi |
| Inspection ZIP | 53555 |
| Inspection start date | Aug 23, 2023 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: